Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CAVA Group Inc (CAVA) vs Medtronic PLC (MDT) Price & Performance

CAVA Group IncTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

CAVA Group Inc vs Medtronic PLC — how do they compare? CAVA Group Inc trades at $68.48 (market cap $7.08B), while Medtronic PLC trades at $90.5 (market cap $116.07B). The key difference: Medtronic PLC is far larger — about 16.4× CAVA Group Inc's market cap, and Medtronic PLC pays a 3.18% dividend while CAVA Group Inc pays none. Which is the better fit depends on your goals.

CAVAMDT
Market Cap
$7.08B$116.07B
Sector
Consumer CyclicalHealth
52-Week High
$97.39$105.35
52-Week Low
$43.59$73.75
Enterprise Value
$7.23B$134.82B
Dividend Yield
3.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CAVA Group Inc

CAVA trades at $62.42, up 0.31% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong revenue growth to $1.18B in 2025 and has beaten earnings estimates in two of the last three quarters. Recent news highlights anticipation for the Q2 2026 earnings report, with analysts citing strong traffic and expansion as positive catalysts.

Wall Street maintains a bullish outlook with a consensus price target of $91.00, though high valuation multiples and recent net cash outflows pose risks. The stock's investment case hinges on continued execution of its growth strategy amid competitive industry pressures.

Medtronic PLC

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CAVA Group Inc

CAVA is a Mediterranean fast-casual restaurant brand in the US. It offers customizable bowls, salads, and pitas featuring healthy ingredients, while also selling its signature dips and dressings in grocery stores.

Read more on CAVA

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT